19 women report 'harmful reactions' to counterfeit Botox in 9 states including WA

Описание к видео 19 women report 'harmful reactions' to counterfeit Botox in 9 states including WA

According to the American Society of Plastic Surgeons, Botox injections are now the most common cosmetic operation with millions of procedures every year.

Now, officials are concerned counterfeit versions of Botox are circulating.

The FDA said at least 19 women between the ages of 25 and 59 have reported "harmful reactions" in nine states including Washington. Nine people were hospitalized.

Investigators said those Botox injections were from unlicensed or untrained people or in places that were not healthcare settings.
--------------------------------------------------
For more on the lead story: https://komonews.com/news/local/harmf...
_______________
Stay up to date with our social media:

KOMO News on Facebook:   / komonews  
KOMO News on Twitter:   / komonews  
KOMO News on Instagram:   / komo4  
KOMO News on TikTok:   / komo4seattle  

Subscribe to KOMO on YouTube:    / @komonews  

Watch more top local news stories:    • Видео  

For all of the day’s top local and national news, visit http://www.komonews.com/
Watch our live newscasts and other live video at https://komonews.com/watch

Download our iOS App: https://itunes.apple.com/us/app/komo-...

Download our Android App: https://play.google.com/store/apps/de...

Have a news tip? Send it directly to us:

Email us: [email protected]
Call the Newsroom: 206.404.4000

KOMO News (ABC 4) provides the latest breaking news, sports, weather, traffic, and local event coverage in the Seattle and Western Washington/Puget Sound area including Bellevue, Redmond, Renton, Kent, Tacoma, Bellingham, Yakima, and surrounding communities

#komo #komonews #komo4 #komo4news #seattle #seattlenews #washingtonnews #botox #plasticsurgery #fda #harmful #counterfeit #healthcare #injection #surgery #outpatient

This video and all Sinclair Broadcast Group content archives of local news and sports coverage are available for your use. For more information contact us at [email protected]

Комментарии

Информация по комментариям в разработке